130 related articles for article (PubMed ID: 32950498)
1. Tetrandrine enhances antitumor effects of the histone deacetylase inhibitor MS-275 in human cancer in a Bax- and p53-dependent manner.
Li H; Xu X; Zhang Y; Tang X; Li W
Eur J Pharmacol; 2020 Dec; 888():173575. PubMed ID: 32950498
[TBL] [Abstract][Full Text] [Related]
2. Synergistic anti-tumour effects of tetrandrine and chloroquine combination therapy in human cancer: a potential antagonistic role for p21.
Mei L; Chen Y; Wang Z; Wang J; Wan J; Yu C; Liu X; Li W
Br J Pharmacol; 2015 May; 172(9):2232-45. PubMed ID: 25521075
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy with protein kinase inhibitor H89 and Tetrandrine elicits enhanced synergistic antitumor efficacy.
Yu M; Liu T; Chen Y; Li Y; Li W
J Exp Clin Cancer Res; 2018 Jun; 37(1):114. PubMed ID: 29866132
[TBL] [Abstract][Full Text] [Related]
4. Autophagy-related gene 7 (ATG7) and reactive oxygen species/extracellular signal-regulated kinase regulate tetrandrine-induced autophagy in human hepatocellular carcinoma.
Gong K; Chen C; Zhan Y; Chen Y; Huang Z; Li W
J Biol Chem; 2012 Oct; 287(42):35576-35588. PubMed ID: 22927446
[TBL] [Abstract][Full Text] [Related]
5. Entinostat combined with Fludarabine synergistically enhances the induction of apoptosis in TP53 mutated CLL cells via the HDAC1/HO-1 pathway.
Zhou Z; Fang Q; Li P; Ma D; Zhe N; Ren M; Chen B; He Z; Wang J; Zhong Q; Wang J
Life Sci; 2019 Sep; 232():116583. PubMed ID: 31226417
[TBL] [Abstract][Full Text] [Related]
6. Tetrandrine induces apoptosis by activating reactive oxygen species and repressing Akt activity in human hepatocellular carcinoma.
Liu C; Gong K; Mao X; Li W
Int J Cancer; 2011 Sep; 129(6):1519-31. PubMed ID: 21128229
[TBL] [Abstract][Full Text] [Related]
7. Synergistic antitumour activity of sorafenib in combination with tetrandrine is mediated by reactive oxygen species (ROS)/Akt signaling.
Wan J; Liu T; Mei L; Li J; Gong K; Yu C; Li W
Br J Cancer; 2013 Jul; 109(2):342-50. PubMed ID: 23807172
[TBL] [Abstract][Full Text] [Related]
8. Tetrandrine induces mitochondria-mediated apoptosis in human gastric cancer BGC-823 cells.
Qin R; Shen H; Cao Y; Fang Y; Li H; Chen Q; Xu W
PLoS One; 2013; 8(10):e76486. PubMed ID: 24098511
[TBL] [Abstract][Full Text] [Related]
9. P38 MAP kinase functions as a switch in MS-275-induced reactive oxygen species-dependent autophagy and apoptosis in human colon cancer cells.
Zhan Y; Gong K; Chen C; Wang H; Li W
Free Radic Biol Med; 2012 Aug; 53(3):532-43. PubMed ID: 22634147
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitor FK228 enhances adenovirus-mediated p53 family gene therapy in cancer models.
Sasaki Y; Negishi H; Idogawa M; Suzuki H; Mita H; Toyota M; Shinomura Y; Imai K; Tokino T
Mol Cancer Ther; 2008 Apr; 7(4):779-87. PubMed ID: 18413792
[TBL] [Abstract][Full Text] [Related]
11. Chidamide, a histone deacetylase inhibitor, functions as a tumor inhibitor by modulating the ratio of Bax/Bcl-2 and P21 in pancreatic cancer.
Zhao B; He T
Oncol Rep; 2015 Jan; 33(1):304-10. PubMed ID: 25384499
[TBL] [Abstract][Full Text] [Related]
12. Histone Deacetylase Inhibitor Enhances the Efficacy of MEK Inhibitor through NOXA-Mediated MCL1 Degradation in Triple-Negative and Inflammatory Breast Cancer.
Torres-Adorno AM; Lee J; Kogawa T; Ordentlich P; Tripathy D; Lim B; Ueno NT
Clin Cancer Res; 2017 Aug; 23(16):4780-4792. PubMed ID: 28465444
[No Abstract] [Full Text] [Related]
13. Preclinical rationale for entinostat in embryonal rhabdomyosarcoma.
Bharathy N; Berlow NE; Wang E; Abraham J; Settelmeyer TP; Hooper JE; Svalina MN; Bajwa Z; Goros MW; Hernandez BS; Wolff JE; Pal R; Davies AM; Ashok A; Bushby D; Mancini M; Noakes C; Goodwin NC; Ordentlich P; Keck J; Hawkins DS; Rudzinski ER; Mansoor A; Perkins TJ; Vakoc CR; Michalek JE; Keller C
Skelet Muscle; 2019 May; 9(1):12. PubMed ID: 31113472
[TBL] [Abstract][Full Text] [Related]
14. Tetrandrine induces G1/S cell cycle arrest through the ROS/Akt pathway in EOMA cells and inhibits angiogenesis in vivo.
Xiao W; Jiang Y; Men Q; Yuan L; Huang Z; Liu T; Li W; Liu X
Int J Oncol; 2015 Jan; 46(1):360-8. PubMed ID: 25355542
[TBL] [Abstract][Full Text] [Related]
15. Phosphodiesterase inhibitor, pentoxifylline enhances anticancer activity of histone deacetylase inhibitor, MS-275 in human breast cancer in vitro and in vivo.
Nidhyanandan S; Boreddy TS; Chandrasekhar KB; Reddy ND; Kulkarni NM; Narayanan S
Eur J Pharmacol; 2015 Oct; 764():508-519. PubMed ID: 26209365
[TBL] [Abstract][Full Text] [Related]
16. Blockade of the ERK pathway enhances the therapeutic efficacy of the histone deacetylase inhibitor MS-275 in human tumor xenograft models.
Sakamoto T; Ozaki K; Fujio K; Kajikawa SH; Uesato S; Watanabe K; Tanimura S; Koji T; Kohno M
Biochem Biophys Res Commun; 2013 Apr; 433(4):456-62. PubMed ID: 23501104
[TBL] [Abstract][Full Text] [Related]
17. Synergistic interaction between tetrandrine and chemotherapeutic agents and influence of tetrandrine on chemotherapeutic agent-associated genes in human gastric cancer cell lines.
Wei J; Liu B; Wang L; Qian X; Ding Y; Yu L
Cancer Chemother Pharmacol; 2007 Oct; 60(5):703-11. PubMed ID: 17256130
[TBL] [Abstract][Full Text] [Related]
18. Discovery of PAT-1102, a novel, potent and orally active histone deacetylase inhibitor with antitumor activity in cancer mouse models.
Hiriyan J; Shivarudraiah P; Gavara G; Annamalai P; Natesan S; Sambasivam G; Sukumaran SK
Anticancer Res; 2015 Jan; 35(1):229-37. PubMed ID: 25550555
[TBL] [Abstract][Full Text] [Related]
19. Plumbagin from a tropical pitcher plant (Nepenthes alata Blanco) induces apoptotic cell death via a p53-dependent pathway in MCF-7 human breast cancer cells.
De U; Son JY; Jeon Y; Ha SY; Park YJ; Yoon S; Ha KT; Choi WS; Lee BM; Kim IS; Kwak JH; Kim HS
Food Chem Toxicol; 2019 Jan; 123():492-500. PubMed ID: 30458268
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitors prime medulloblastoma cells for chemotherapy-induced apoptosis by enhancing p53-dependent Bax activation.
Häcker S; Karl S; Mader I; Cristofanon S; Schweitzer T; Krauss J; Rutkowski S; Debatin KM; Fulda S
Oncogene; 2011 May; 30(19):2275-81. PubMed ID: 21562496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
